Company / Assets per Share
Eloxx Pharmaceuticals, Inc. Assets per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$0.54
FY2025
5-year range
$0.49 / $14.67
FY2021-FY2025
Trend
+10.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share returned to growth in FY2025 after 2 years of decline, reaching $0.54.
Based on SEC 10-K filings.
0.54 in FY2025 with a 10-year CAGR of -9.1%.
Declined from $1.41 to $0.54 over the past 10 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -9.1%
Key checks
Key Insights
- In FY2025, assets per share increased 10.7% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -40.59 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.54 | +10.7% |
| FY2016 | $0.49 | -65.2% |
| FY2015 | $1.41 | -90.4% |
| FY2014 | $14.67 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026